June 27, 2023 by Chain Drug Review
2023., Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2023, Walgreens Boots Alliance, which ended May 31
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) on Tuesday reported mixed results for its third quarter, beating analysts’ sales estimates but falling short of profit expectations. Sales for the period ended May 31 advanced 8.6% from the year-ago quarter to $35.4 billion, topping Wall Street’s forecast of $33.79 billion. But adjusted earnings per share came
October 12, 2021 by Chain Drug Review
Anita Allemand, Holly May, Roz Brewer, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance has filled two key executive leadership positions, the company said on Tuesday. Holly May was appointed executive vice president and global chief human resources officer and Anita Allemand was appointed chief transformation and integration officer. May and Allemand will both report to WBA CEO Roz Brewer, as members of
January 25, 2021 by Chain Drug Review
James Skinner, Stefano Pessina, Walgreens Boots Alliance
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) will hold its virtual annual stockholders’ meeting on Jan. 28, 2021 at 8:00 a.m. CST. A live audio webcast of the meeting will be available through the WBA investor relations website at https://investor.walgreensbootsalliance.com. A replay of the meeting will be archived on the website for 12 months after the
January 7, 2021 by Jeffrey Woldt
AmerisourceBerge, Stefano Pessina, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy
DEERFIELD, Ill. — Walgreens Boots Alliance and AmerisourceBergen yesterday took the next but far from final step in their long-standing partnership, when the former agreed to sell the latter most of Alliance Healthcare. Valued at some $6.5 billion, the deal will bring AmerisourceBergen’s pharmaceutical distribution and health care solutions business to 13 countries, mostly in
July 17, 2020 by Chain Drug Review
2020 Disability Equality Index (DEI), a joint initiative by Disability:IN and the American Association of People with Disabilities (AAPD)., Carlos Cubia, Inc., Walgreens, Walgreens Boots Alliance
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens has been recognized for the fourth consecutive year with a top score of 100% on the 2020 Disability Equality Index (DEI), a joint initiative by Disability:IN and the American Association of People with Disabilities (AAPD). The DEI is considered the most comprehensive benchmarking tool for corporate disability inclusion and was developed
April 16, 2020 by Alex Gourlay
Alex Gourlay, coronavirus, COVID-19, Walgreens Boots Alliance, WBA
Featured Articles, Leading Headlines, Opinion
Editor’s note: This is part of a series of articles on how retailers are responding to the COVID-19 crisis. I have worked in pharmacies for more than 40 years, and I’m a pharmacist myself. I’ve never known a situation like what we’ve experienced over recent weeks with the COVID-19 crisis. None of us has. This
March 10, 2020 by Chain Drug Review
Alex Gourlay, INFORM Consumers Act, Walgreens Boots Alliance
Leading Headlines, Retail News
DEERFIELD, Ill. — In support of the bipartisan INFORM Consumers Act introduced Tuesday by Senators Bill Cassidy and Dick Durbin, Walgreens issued the following statement from Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance: “The lack of transparency and accountability in today’s digital marketplaces has contributed to the rapid rise of organized retail crime,
February 11, 2020 by Chain Drug Review
019 Corporate Social Responsibility (CSR) Report, Alliance Healthcare and Walgreens, Boots Ireland, Boots UK, Dr. Nikhil Harikrishnan, Sebastian James, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
LONDON — Walgreens Boots Alliance (WBA) announced on Tuesday the publication of its “Corporate Social Responsibility (CSR) Report 2019,” which details the company’s global sustainability initiatives, including efforts to improve access to quality health care, deliver support programs for people living with cancer and reduce the company’s carbon footprint. WBA is a leading global pharmacy
January 6, 2020 by Chain Drug Review
AmerisourceBergen, Capsule, Cardinal Health, Care Pharmacies, CVS Health, Discount Drug Mart, Fruth Pharmacy, Genoa Healthcare, Good Neighbor Pharmacy, Health Mart, Lewis Drug, London Drugs, McKesson Canada, Medicine Shoppe International, Pharmaca Integrative Pharmacy, PharmaChoice, Pharmasave Drugs National, Rite Aid, Senderra, Wakefern Food Corp., Walgreens Boots Alliance, Walmart U.S.
January 6, 2020
DIR fees are again top of mind for pharmacy operators beginning another year without relief from these “phantom” expenses. At the same time hope springs eternal for retailers looking to broaden affordable and accessible health care offerings when such services from more traditional providers can be out of financial reach for many people. Chains also
November 11, 2019 by Chain Drug Review
KKR & Co., Walgreens Boots Alliance
Business, Leading Headlines, Retail News
NEW YORK — According to published reports, KKR & Co. has formally approached Walgreens Boots Alliance about a deal to take the company private, in what could be the biggest-ever leveraged buyout. The New York-based private equity firm has been preparing a proposal to potentially buy out shareholders of Walgreens Boots, said the people, who
October 2, 2019 by Chain Drug Review
Ken Murphy, Tesco, Tesco boss Dave Lewis, Walgreens Boots Alliance
Business, Retail News
LONDON — Tesco chief executive officer Dave Lewis announced Wednesday that he will step down next summer after declaring the company’s turnaround complete. Celebrating its 100th anniversary, Tesco is five years into a recovery plan launched by Lewis after an accounting scandal capped a dramatic downturn in trading. Successor Ken Murphy, a former executive at
June 27, 2019 by Chain Drug Review
Stefano Pessina, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance’s (WBA’s) third quarter profit beat analysts’ expectations, as U.S. pharmacy sales rose 4.3% in the period ended May 31. Net earnings slipped 23.6% to $1 billion compared to the year-ago quarter, while net earnings per share decreased 16.5% to $1.13. Stripping out special items, the company earned $1.47 per
May 28, 2019 by Chain Drug Review
Collaboration for Cancer Prevention, European Organization for Research and Treatment of Cancer, Macmillan Cancer Support, Ornella Barra, Research and Support, Susan G. Komen Breast Cancer Foundation, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance has entered into a charitable partnership with European and American cancer organizations “to support people living with cancer at all moments of their journey.” The Collaboration for Cancer Prevention, Research and Support will cooperate on initiatives to develop and support innovative cancer research infrastructure and share best practices to
February 22, 2019 by Chain Drug Review
James Kehoe, th Annual SVB Leerink Global Healthcare Conference, Walgreens Boots Alliance
Business, Leading Headlines
DEERFIELD, Ill. – Walgreens Boots Alliance announced Friday that global chief financial officer James Kehoe will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference, Thursday, February 28 at 3:00 p.m. Eastern time. The conference is being held at Lotte New York Palace in New York City. An audio portion of